ロード中...

Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer

Metastatic disease ultimately occurs in approximately 50–70% of patients presenting with colorectal cancer. In patients with advanced disease, there is significant variability in individual patient outcomes. To improve understanding of tumor behavior, markers such as KRAS and BRAF mutation status ar...

詳細記述

保存先:
書誌詳細
出版年:Surg Oncol
主要な著者: Ronnekleiv-Kelly, Sean M., Burkhart, Richard A., Pawlik, Timothy M.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5152574/
https://ncbi.nlm.nih.gov/pubmed/27566022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suronc.2016.05.018
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!